Roth Capital Has Negative View of Globus Medical Q1 Earnings
Globus Medical, Inc. (NYSE:GMED – Free Report) – Research analysts at Roth Capital lowered their Q1 2025 earnings estimates for Globus Medical in a research report issued to clients and investors on Thursday, March 13th. Roth Capital analyst J. Wittes now anticipates that the medical device company will post earnings per share of $0.71 for […]
Globus Medical, Inc. (NYSE:GMED – Free Report) – Research analysts at Roth Capital lowered their Q1 2025 earnings estimates for Globus Medical in a research report issued to clients and investors on Thursday, March 13th. Roth Capital analyst J. Wittes now anticipates that the medical device company will post earnings per share of $0.71 for […]
